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Healthcare disparities
Community health centersObjective. Colorectal cancer (CRC) screening rates remain lower among some racial/ethnic groups and indi-
viduals with low income or educational attainment who are often cared for within community health centers
(CHCs). We surveyed clinicians in a network of CHCs to understand their attitudes, practice patterns, and
perceived barriers to CRC screening.
Methods. A clinician surveywas conducted in 2013within the Community Health Applied Research Network
(CHARN).
Results. 180 clinicians completed the survey (47.9% response rate). Participants had an average of 11.5 (SD:
9.8) years in practice, 62%were female, and 57%were physicians. Themajority of respondents somewhat agreed
(30.2%) or strongly agreed (57.5%) that colonoscopy was the best screening test. However, only 15.8% of respon-
dents strongly agreed and 32.2% somewhat agreed that colonoscopywas readily available for their patients. Fecal
immunochemical testing (FIT), a type of fecal occult blood test (FOBT),was viewed less favorably; 24.6% rated FIT
as very effective.
Conclusions. Although there are no data showing that screening colonoscopy is superior to FIT, CHC clinicians
believe colonoscopy is the best CRC screening test for their patients, despite the high prevalence of ﬁnancial bar-
riers to colonoscopy. These attitudes could be due to lack of knowledge about the evidence supporting long-term
beneﬁts of fecal occult blood testing (FOBT), lack of awareness about the improved test characteristics of FIT com-
pared to older guaiac-based FOBT, or the absence of systems to ensure adherence to regular FOBT screening.
Interventions to improve CRC screening at CHCs must address clinicians' negative attitudes towards FIT.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The United States Preventive Services Task Force (USPSTF) recom-
mends that average-risk adults age 50–75 be screened for colorectal can-
cer (CRC) using annual fecal occult blood testing (FOBT), ﬂexible
sigmoidoscopy every ﬁve years, or colonoscopy every ten years
(USPSTF, 2008). Currently only 60–65% of the eligible US population isbrook Terrace, IL 60181, United
aker).
. This is an open access article underup-to-date on CRC screening (Liss and Baker, 2014; Shapiro et al.,
2012; CDC, 2013). Screening rates are considerably lower among
Hispanics, Asians, individuals with low socioeconomic status, and the
uninsured (Liss and Baker, 2014; Klabunde et al., 2011; Meissner et al.,
2006; Holden et al., 2010).
Community health centers (CHC) can play an important role in ad-
dressing these disparities, and this has long been a high national priority
for the Health Resources and Services Administration (HRSA), which
requires reporting of CHC-level CRC screening rates (HRSA, 2012).
However, achieving high screening rates within CHCs is challenging.
We found that among CHCs participating in the Community Healththe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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was 31%, and the screening rate ranged from 10% to 67% (Baker et al.,
2015). Most screenings were by colonoscopy, despite its cost. Only
one of twelve participating CHCs had most screenings done by FOBT.
The heavy reliance on colonoscopy for CRC screening is consistent
with national data showing that even among individuals living in pover-
ty and thosewho are uninsured, themost commonCRC screening test is
colonoscopy (CDC, 2013). The overwhelming reliance on colonoscopy
for CRC screening is contrary to the available evidence on the effective-
ness of different CRC screening modalities. The Minnesota Colorectal
Cancer Control Study randomized patients to no screening or annual
guaiac-based FOBT screening (Mandel et al., 1993). Annual FOBT
screening decreased CRC mortality by 33%. In contrast, no randomized
controlled trial has examined the effect of colonoscopy on mortality. A
recent nested case control study followed participants from the Nurses'
Health Study and the Health Professionals Follow-up Study and found
that those who had screening colonoscopy had a multivariate hazard
ratio for death from CRC of 0.32 compared those who did not have
any form of endoscopy (Nishihara et al., 2013). Thus, although there is
evidence that colonoscopy reduces CRC mortality, there is no evidence
that colonoscopy is more effective than FOBT, especially with the im-
proved test performance characteristics of fecal immunochemical tests
(FIT) compared to older guaiac-based FOBT. The USPSTF has not recom-
mended one screening modality over another (Pignone et al., 2002;
USPSTF, 2008). When patient preferences for screening modality are
formally elicited, approximately equal numbers choose colonoscopy
and FOBT (Hawley et al., 2008, 2012; DeBourcy et al., 2008). This has
led some to suggest the “best” CRC screeningmodality is the one the pa-
tient completes (Woolf, 2000; Sarfaty et al., 2013).
Few previous studies have examined attitudes about CRC screening
among clinicians caring for vulnerable populations (O'Malley et al.,
2004; Haverkamp et al., 2011; Rim et al., 2009; Hatcher et al., 2011;
Kelly et al., 2007), andwe are not aware of any study reporting on clini-
cian attitudes and CRC screening practices within a network of CHCs.
There are possible challenges to achieving high rates of CRC screening
at CHCs, including knowledge and attitudes towards screening
(Berkowitz et al., 2008; Jun and Oh, 2013), inadequate time and re-
sources to counsel patients (Yarnall et al., 2003), and a high prevalence
of patients with barriers to endoscopy (Beydoun and Beydoun, 2008).
There are also potential barriers to screening with FOBT, including the
need for annual testing (Liss et al., 2013) and the need to complete diag-
nostic colonoscopy for those with positive results (Nadel et al., 2010).
Consequently, some clinicians may not believe that FOBT is effective
for many of their patients.
We conducted this study to understand CHC clinicians' perceptions
of the importance of CRC screening relative to other preventive services,
perceived effectiveness of different screening modalities, patient and
system-level barriers to CRC screening, quality improvement (QI) and
population health management methodologies used to improve CRC
screening, and QI methodologies perceived to produce the greatest im-
provements in CRC screening. To accomplish this, we surveyed adult
medicine clinicians at CHCs that were part of CHARN.
Methods
Study setting
Twelve CHCs in the CHARNnetwork fromaround the country partic-
ipated in this study: Near North Health Service Corporation, Erie Family
Health Center, Heartland Health Outreach, Howard Brown Health Cen-
ter, and PCC Community Wellness Center in Chicago, Illinois; North
CountryHealthcare in Flagstaff, Arizona; FenwayHealth in Boston,Mas-
sachusetts; Beaufort Jasper Hampton Comprehensive Health Services in
South Carolina; Chase Brexton Health Care in the Baltimore, Maryland
area; Virginia Garcia Memorial Health Center in Hillsboro, Oregon;
OHSU Richmond Family Medicine in Portland, Oregon; and Open DoorCommunity Health Centers in northern California. Participating CHCs
serve a variety of vulnerable and historically underserved groups that
reﬂect the geographic and cultural heterogeneity of CHARN, including
(but not limited to) African Americans, Hispanics and Latinos,
American Indians, the LGBT community, the uninsured and underin-
sured, and people living near or below the federal poverty level. All
sites agreed to participate with the understanding that only aggregate
data would be shared (i.e., no linkage to patient-level data) and screen-
ing rates would be reported anonymously. The Kaiser Permanente Cen-
ter for Health Research houses the CHARN Data Coordinating Center
(DCC). Study protocols were approved by the Institutional Review
Board or internal research committee at all participating sites and
organizations.
Survey instrument
CHARN created a CRC Screening Workgroup (“workgroup”) with
representatives from these participating health centers to identify
ways to improve CRC screening rates. In 2012, theworkgroup collabora-
tively developed the survey instrument.Many itemswere adapted from
previous provider surveys about CRC screening (Hoffman et al., 2011;
Klabunde et al., 2003, 2009). In addition, the survey included items
aimed at understanding barriers and facilitators to screening within
the CHC environment speciﬁcally.
The DCC created a web-based survey and corresponding data collec-
tion/tracking systems using SURVEYGEN software. The survey instru-
ment was pilot tested by study authors and minor revisions were
made to improve survey clarity and ﬂow. The survey contained 32
items and took approximately 10 minutes to complete. The survey
had ﬁve main domains: (1) perceived importance of CRC screening rel-
ative to other preventive services; (2) perceived effectiveness of differ-
ent CRC screening modalities; (3) usual CRC screening practices;
(4) perceived barriers to screening; and, (5) beliefs about the effective-
ness of strategies to improve screening. We speciﬁed that all items re-
ferred to screening procedures to reduce CRC mortality in average-risk
patients 50 years and older. Based on current USPSTF recommenda-
tions,(2008) the survey included items regarding FOBT, ﬂexible sig-
moidoscopy, and colonoscopy. For items relating to FOBT, we speciﬁed
whether we were referring to FOBT (any method or test) or speciﬁcally
to guaiac-based FOBT or fecal immunochemical tests (FIT).
Survey administration
All primary care clinicians (physicians, advanced practice nurses,
and physician assistants) at participating CHCs who cared for adult pa-
tients age 50 and older were invited to participate. A site champion at
each CHC identiﬁed eligible clinicians at their site and shared clinicians'
email addresses with the CHARN DCC.
The online survey was administered in April–June 2013. Shortly
following the site champion's study introduction email, automated
recruitment emails were sent to all eligible clinicians. Each email
contained a unique survey hyperlink to track survey completion. The
survey did not ask for any identifying information. Two weeks after
this initial invitation, the site champion sent a general reminder email
and DCC resent recruitment emails to clinicians who had not yet
responded. A ﬁnal reminder was sent four weeks following initial invi-
tation. Following a poor response to the online survey, one health center
also included a paper-based survey completion option. Participants
were emailed a $5 e-gift card within a week of survey completion. The
CHARN DCC matched each completed survey back to each participant's
CHC. The study team was blind to CHC identity.
Statistical analysis
We calculated descriptive statistics to summarize provider charac-
teristics, beliefs about CRC screening and screening practice patterns.
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stratiﬁed by provider type (e.g., MD vs. other) and CHC site. All analyses
were done using SAS V 9.3 (SAS Institute Inc., NC, USA).
Results
Of 376 eligible clinicians, 180 participated in the survey (response
rate 47.9%). The response rate varied between 17–80% by site (AAPOR,
2011). Participants had an average of 11.5 (SD: 9.8) years in practice,
saw a mean of 58.5 (SD: 23.7) patients each week, 62% were female,
and 57% were MDs.
CRC screening importance
Themajority of clinicians thought CRC screeningwas as ormore im-
portant than other preventive services. Most clinicians said CRC screen-
ing was as important as breast and cervical cancer screening (73.3% for
both screenings); of the remaining 26.7%, approximately equal numbers
rated CRC screening as less important ormore important. Approximately
half (47.7%) said CRC screeningwasmore important than TDaP immuni-
zation, and 39.4% said it wasmore important than pneumococcal vacci-
nation for patients age ≥65. Conversely, 44.3% said smoking cessation
counseling was more important than CRC screening.
Self-reported rates of CRC screening recommendations
Participants reported that they recommend CRC screening to the
majority of eligible patients; 63.3% said that they recommended screen-
ing to over 75% of eligible patients, and 21.7% reported advising 51–75%
of eligible patients. Of note, most clinicians reported that a markedly
lower percentage of their patients are actually up-to-date on CRC
screening; 29.4% reported 26–50% of patients are up-to-date; 37.2% re-
ported 51–75% are up-to-date, and; 7.2% reported greater than 75%
were up-to-date. The most common screening modality recommended
was colonoscopy; 37% reported they recommend colonoscopy without
discussing other modalities.
Perceptions of CRC screening modalities
Table 1 shows clinicians' perceptions of each screening modality's
effectiveness. The vast majority (92.7%) believed that colonoscopy is
very effective. Far fewer reported FIT and ﬂexible sigmoidoscopy as
very effective (24.6% and 24.0% respectively). Less than 10% of partici-
pants reported guaiac-based FOBT as very effective, though only 12.8%
reported it as not effective. Of note, 15.6% of participants responded
“don't know” for FIT, far more than any other modality. When asked
speciﬁcally about in-ofﬁce FOBT, over one-fourth of respondents said
thiswas a somewhat effective screening strategy. Perceptions of screen-
ing modality varied by provider type (MD vs. other provider); physi-
cians believed guaiac-based FOBT and FIT to be more effective than
other clinicians.
The overwhelming majority somewhat agreed (30.2%) or strongly
agreed (57.5%) that colonoscopy was the best screening test (Table 2).
This ﬁnding was consistent across all sites, and did not signiﬁcantlyTable 1
Perceptions of CRC screening modality effectivenessa.
Very effective
n (%)
Som
n (
Guaiac-based FOBTb 16 (8.9) 135
Immunochemical FOBT (FIT) 44 (24.6) 101
Flexible Sigmoidoscopy 43 (24.0) 126
Colonoscopy 166 (92.7) 13
In-ofﬁce FOBT 0 48
a A total of 179 participants completed these items. One skipped all items in this section.
b FOBT = fecal occult blood test; FIT = fecal immunochemical test.differ by provider type. Respondents reported numerous patient-level
barriers to colonoscopy. Only 15.8% strongly agreed and 32.2% some-
what agreed that colonoscopy was readily available for their patients.
Lack of insurance or inadequate insurance was commonly mentioned
as a barrier to colonoscopy; 75% of participants said this was sometimes
or usually a barrier to screening colonoscopy and 47.2% reported this
was sometimes or usually a barrier to diagnostic colonoscopy. Only
13.9% reported that a shortage of local endoscopists was sometimes or
usually a barrier to screening colonoscopy.
Perceived patient knowledge and attitude barriers to CRC screening
Clinicians reported that patients' knowledge and attitudes about
CRC screeningwere often barriers (Table 3), including patients not per-
ceiving CRC as a serious health threat, lack of awareness of CRC screen-
ing, lack of desire to discuss CRC screening, and difﬁculty understanding
the information clinicians present about CRC screening. However, these
perceived patient barriers did not affect most clinicians' screening prac-
tices; only 8.6% said they sometimes or usually did not order a CRC
screening test because they thought a patient was unlikely to complete
it.
Strategies being used to facilitate CRC screening
System-level supports for CRC screening were available to a minori-
ty of respondents (Table 4). Approximately one third (36.9%) received
regular quality reports on their screening rates. Patient education
about CRC screening was done mostly by clinicians (96.1%). Only
44.4% of respondents said that staff conduct patient education, and
32%mail letters to patients. Most clinicians (89.2%) reported availability
of health maintenance ﬂow sheets in their electronic health record
(EHR) that could be reviewed to determine patients' screening status.
However, only 37.3% reported having EHR alerts to remind them that
a patient being seen is due for CRC screening. Approximately one third
(30.5%) reported their practice has a mechanism to offer screening
without their direct involvement; the most common mechanism was
distribution of FOBT kits by clinic staff.
Strategies to facilitate completion of home FOBTs
A total of 152 respondents (84.4%) said they give patients FOBTs to
complete at home. Among these respondents, only 29 (19.1%) reported
they hadmechanisms to ensure patients returned completed FOBTs, in-
cluding reminder calls (7.2%),mailed reminders (4.6%), chart reminders
for next visit (8.6%), or other mechanisms (3.9%). Only 62 (40.8%) re-
ported having a mechanism to ensure patients with positive FOBT re-
sults completed follow-up diagnostic colonoscopy; the most common
mechanisms included telephone calls (23.7%), tracking or scheduling
systems (21.1%), and mailed reminders (13.2%).
Perceived helpfulness of interventions
When asked about perceived helpfulness of potential interventions
to improve CRC screening, the majority responded it would beewhat Effective
%)
Not effective
n (%)
Don't know
n (%)
(75.4) 23 (12.8) 5 (2.8)
(56.4) 6 (3.4) 28 (15.6)
(70.4) 7 (3.9) 3 (1.7)
(7.3) 0 0
(26.8) 125 (69.8) 6 (3.4)
Table 2
Provider perceptions about screening colonoscopya.
Strongly disagree
n (%)
Somewhat disagree
n (%)
Somewhat agree
n (%)
Strongly agree
n (%)
It is the best screening test (n = 179) 4 (2.2) 18 (10.1) 54 (30.2) 103 (57.5)
It is readily available for my patients (n = 177) 40 (22.6) 52 (29.4) 57 (32.2) 28 (15.8)
It is available, but many of my patients face ﬁnancial barriers to screening
colonoscopy (n = 178)
13 (7.3) 18 (10.1) 63 (35.4) 84 (47.2)
I worry that I might be sued if I do not offer this test to my patients (n = 178) 67 (37.6) 65 (36.5) 38 (21.3) 8 (4.5)
a Some of the 180 respondents did not complete one or more of these questions. The actual number of respondents is shown in parentheses.
Table 4
Facilitators to CRC screeninga.
n (%)
Regularly receives quality reports on CRC screening, (n = 179) 66 (36.9)
Currently uses the following strategies to educate patients
about CRC screening: (n = 178)
Posters/brochures in waiting room 43 (24.2)
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(93.7%) and clinicians (87.9%) of which patients need screening
(Table 5). Improving access to diagnostic colonoscopy was reported as
somewhat or very helpful by 147 clinicians (84.5%). Only 57.1% said
that mailing FOBTs to patients would be somewhat or very helpful.
Discussion
This study provides important information about attitudes of CHC
clinicians regarding CRC screening. Respondents overwhelmingly be-
lieve that colonoscopy is the best CRC screeningmodality, which is con-
sistent with previous reports across a variety of settings (Hoffman et al.,
2011; Klabunde et al., 2003, 2009; Hawley et al., 2001; Guerra et al.,
2007; Levy et al., 2007; Nichols et al., 2009; Feeley et al., 2009). This per-
ception amongproviders is probably amajor reasonwhy colonoscopy is
thepredominant screeningmodality across theU.S. and theCHARNCHC
network. The reasons why clinicians hold colonoscopy in such high re-
gard are unclear. Randomized controlled studies have shown that
guaiac-based FOBT screening substantially reduces CRC mortality
(Mandel et al., 1993), while screening colonoscopy has not been studied
as rigorously. It may seem intuitive that a visual inspection of the colon
would be a better test than FOBT, but recent studies have shown wide
variability in the quality of colonoscopy based on adenoma detection
rates (Corley et al., 2014). In addition, FOBT has greatly improved with
the introduction of FIT, which has better test characteristics than older
guaiac-based tests (Lee et al., 2014). There is no evidence that colonos-
copy ismore effective than FOBT, although studies are underway. Efforts
are needed to provide physicians with a more accurate picture of CRC
screening options.
Clinicians' belief in colonoscopy as the gold standard is juxtaposed
against the high level of access barriers to colonoscopy reported by
many CHC clinicians. Unless the Affordable Care Act initiates dramatic
growth in CHC patients' access to colonoscopy, substantially increasing
colonoscopy use among CHC patients will be difﬁcult. CHCsmay be able
to reduce colonoscopy access barriers by developing networks of gas-
troenterology specialists to provide free colonoscopies (including
costs of biopsy pathology and polyp removal) or through creation ofTable 3
Perceived patient knowledge and attitude barriers to CRC screeninga.
Report encountering barrier
“Sometimes” or “Usually” n (%)
My patients do not perceive colorectal cancer
as a serious health threat. (n = 175)
141 (80.6)
My patients are unaware of colorectal cancer
screening (n = 177)
102 (57.6)
My patients do not want to discuss colorectal
screening (n = 177)
82 (46.3)
My patients have difﬁculty understanding the
information I present about colorectal cancer
screening (n = 174)
79 (45.4)
You do not order a CRC screening test because
you think the patient is unlikely to complete
test. (n = 175)
15 (8.6)
a Some of the 180 respondents did not complete one or more of these questions. The
actual number of respondents is shown in parentheses.state or local programs to provide ﬁnancial support for screening
colonoscopy.
Given the reported barriers to colonoscopy, and the difﬁculty of
overcoming these barriers for the majority of CHC patients, wider
FOBT use is likely the most practical solution to improving CRC screen-
ing rates among CHC patients. However, there are multiple challenges.
Most survey participants do not think FOBT is very effective, even
when FIT is used. Also, over a quarter of them thought that in-ofﬁce
FOBT (e.g., following a rectal exam) is somewhat effective for screening,
in contrast to current recommendations (Collins et al., 2005). It is possi-
ble some clinicians think in-ofﬁce FOBT is better than no screening at all
for patientswith barriers to othermodalities. Thus, efforts are needed to
educate clinicians about proper FOBT use, especially with regard to im-
proved accuracy and convenience of FITs. Even if most clinicians still
think colonoscopy is most effective, they should understand that FOBT
is a reasonable alternative if preferred by the patient or if colonoscopy
is unavailable. However, for screeningwith FOBT to reduce CRCmortal-
ity, CHCs will need to implement programs that ensure high adherence
to annual FOBT and, among patients with positive tests, high rates of di-
agnostic colonoscopy. Currently, many clinicians do not have these pro-
grams in place.
Our ﬁndings highlight the need for CHCs to have system-level ap-
proaches to educating patients about CRC screening. In addition to
reporting numerousﬁnancial barriers to screening, clinicians also report
perceived patient barriers such as lack of awareness of the need for
screening, and the majority lack systems to educate patients outside
of provider discussions. These barriers place a large burden on CHC cli-
nicians to educate patients about their CRC risk, the importance of
screening, and available screening options. It may also be beneﬁcialBrochures given to patients 21 (11.8)
Clinicians discuss screening with patients 171 (96.1)
Staff discuss screening with patients 79 (44.4)
Electronic media in waiting room 5 (2.8)
Letters mailed to patients 57 (32.0)
Other 3 (1.7)
None of the above 2 (1.1)
Have access to the following to remind me who is due for
CRC screening:
Health maintenance ﬂow sheet (n = 176) 157 (89.2)
Alert or prompt in electronic health record (n = 177) 66 (37.3)
Staff reviews patient record and notiﬁes me (n = 177) 68 (38.4)
Other (n = 177) 9 (5.1)
None (n = 177) 3 (1.7)
Practice has a mechanism to offer screening w/o my direct
involvement (e.g., MAs give out FOBTs, standing orders) (n = 177)
54 (30.5)
Medical assistant or other staff hands out an FOBT kit 40 (22.6)
Standing orders to refer for endoscopy 5 (2.8)
Other 10 (5.6)
a Some of the 180 respondents did not complete one ormore of these questions. The
actual number of respondents is shown in parentheses.
Table 5
Perceived helpfulness of interventions to increase CRC screening ratesa.
Report intervention would be
“somewhat” or “very” helpful,
n (%)
Implement EHR alert to notify staff which patients
need screening (n = 174)
163 (93.7)
Implement EHR alert to notify clinicians which
patients need screening (n = 174)
153 (87.9)
Improve access to diagnostic colonoscopy for
patients with a positive FOBT (n = 174)
147 (84.5)
Generate a list of patients coming in each day who
need screening (n = 175)
136 (77.7)
Mail FOBT test kits to patients who are due for
screening (n = 175)
100 (57.1)
a Some of the 180 respondents did not complete one or more of these questions. The
actual number of respondents is shown in parentheses.
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posed to CRC screening messages prior to clinician encounters. These
initiatives may help establish CRC screening as a social norm so patients
are more likely to accept clinicians' screening recommendations.
In previous studies, clinicians have reported perceived patient bar-
riers more often affect CRC screening than system-level barriers
(Hoffman et al., 2011; Hawley et al., 2001; Klabunde et al., 2005). The
most commonly reported perceived patient barrier is concern regarding
patient compliance or the belief that patients are unlikely to complete
screening (Hawley et al., 2001; Zapka et al., 2011; Dulai et al., 2004;
Sewitch et al., 2006). Clinicians in our study claim that patient barriers
do not affect practice and most believe they recommend CRC screening
to the vast majority of eligible patients. However, these perceived pa-
tient barriers could subtly inﬂuence provider recommendations. For ex-
ample, it may be difﬁcult to annually motivate patients to complete
FOBT if clinicians knowmany patients struggle to adhere to this recom-
mendation, and when organizational supports are less than ideal.
Our study has several limitations. The response ratewas 47%, and re-
spondents could be more likely than other clinicians to believe in CRC
screening's importance. We had no data on non-responders' individual
characteristics, so we cannot assess how they differed from respon-
dents. One major limitation is our inability to match respondents' esti-
mated CRC screening adherence rates to their actual screening rates.
Clinicians probably overestimate how often they offer CRC screening
to patients. Finally, we did not survey patients. The perceived barriers
reported by clinicians could differ substantially from the actual barriers
reported by patients. However, our interest was in clinician's percep-
tions and how that might affect their delivery of CRC screening.
This study provides insight regarding CHC clinician perspectives on
CRC screening. The twelve participating sites are geographically diverse
and have unique patient populations. Additionally, inclusion of non-MD
clinicians in our sample is a strength, given that CHCs are relying more
on team-based care, in accordancewith recommended strategies to im-
prove overall screening rates (Klabunde et al., 2007). It is therefore im-
portant to understand non-MD clinicians' perspectives and practice
patterns.
This study has several important implications. Results highlight the
need to address patient, provider, and system-level barriers to CRC
screening. First, educational efforts are needed to inform CHC clinicians
about the 18–33% reduction in CRC mortality that have been achieved
with FOBT in randomized controlled trials (Mandel et al., 1993;
Kronborg et al., 1996), advantages of newer FITs (Vart et al., 2012;
Liles et al., 2012), and successful strategies to increase adherence to
CRC screening using FIT among patients at CHCs. Second, nationwide
programs are needed to help CHCs implement successful strategies to
improve CRC screening, including point-of-care electronic reminders,
patient reminders, outreach programs, and access to screening colonos-
copy. Care management programs to navigate patients with positive
FOBTs to diagnostic colonoscopy are also critical, as is funding to reduceﬁnancial barriers to both colonoscopy and pathology tests to evaluate
biopsy specimens. This is an opportune time to augment efforts to im-
prove CRC screening at CHCs given HRSA's requirement that CHCs pub-
licly report their CRC screening rates (HRSA, 2012) and the likelihood
that CRC screening will be a major QI target at many CHCs.
Conﬂict of interest
The authors declare that there are no conﬂicts of interests.
Acknowledgments
Funding support was provided by the Health Resources and Services
Administration (#UB3HA20236) and by the Agency for Healthcare Re-
search and Quality (#P01HS21141). The sponsors had no role in study
design; in the collection, analysis and interpretation of data; in thewrit-
ing of the report; or in the decision to submit the article for publication.
The authors gratefully acknowledge the members of CHARN's commu-
nity health centers, research node centers, and data coordinating center
for their support throughout this project and the preparation of this
article.
References
AAPOR, 2011. Standard Deﬁnitions: Final Dispositions of Case Codes and Outcome Rates
for Surveys. The American Association for Public Opinion Research 7th ed.
Baker, D.W., Liss, D.T., Alperovitz-Bichell, K., Brown, T., Carroll, J.E., Crawford, P., Harigopal,
P., Henley, E., Nelson, C.A., Rittner, S.S., 2015. Colorectal cancer screening rates at
community health centers that use electronic health records: a cross sectional
study. J. Health Care Poor Underserved 26, 377–390.
Berkowitz, Z., Hawkins, N.A., Peipins, L.A., White, M.C., Nadel, M.R., 2008. Beliefs, risk per-
ceptions, and gaps in knowledge as barriers to colorectal cancer screening in older
adults. J. Am. Geriatr. Soc. 56, 307–314.
Beydoun, H.A., Beydoun, M.A., 2008. Predictors of colorectal cancer screening behaviors
among average-risk older adults in the United States. Cancer Causes Control 19,
339–359.
Centers for Disease Control and Prevention (CDC), 2013. Vital signs: colorectal cancer
screening test use—United States, 2012. Morb. Mortal. Wkly Rep. 62, 881–888.
Collins, J.F., Lieberman, D.A., Durbin, T.E., Weiss, D.G., 2005. Accuracy of screening for fecal
occult blood on a single stool sample obtained by digital rectal examination: a com-
parison with recommended sampling practice. Ann. Intern. Med. 142, 81–85.
Corley, D.A., Jensen, C.D., Marks, A.R., Zhao, W.K., Lee, J.K., Doubeni, C.A., Zauber, A.G., De
Boer, J., Fireman, B.H., Schottinger, J.E., Quinn, V.P., Ghai, N.R., Levin, T.R.,
Quesenberry, C.P., 2014. Adenoma detection rate and risk of colorectal cancer and
death. N. Engl. J. Med. 370, 1298–1306.
Debourcy, A.C., Lichtenberger, S., Felton, S., Butterﬁeld, K.T., Ahnen, D.J., Denberg, T.D.,
2008. Community-based preferences for stool cards versus colonoscopy in colorectal
cancer screening. J. Gen. Intern. Med. 23, 169–174.
Dulai, G.S., Farmer, M.M., Ganz, P.A., Bernaards, C.A., Qi, K., Dietrich, A.J., Bastani, R.,
Belman, M.J., Kahn, K.L., 2004. Primary care provider perceptions of barriers to and fa-
cilitators of colorectal cancer screening in a managed care setting. Cancer 100,
1843–1852.
Feeley, T.H., Cooper, J., Foels, T., Mahoney, M.C., 2009. Efﬁcacy expectations for colorectal
cancer screening in primary care: identifying barriers and facilitators for patients and
clinicians. Health Commun. 24, 304–315.
Guerra, C.E., Schwartz, J.S., Armstrong, K., Brown, J.S., Halbert, C.H., Shea, J.A., 2007. Bar-
riers of and facilitators to physician recommendation of colorectal cancer screening.
J. Gen. Intern. Med. 22, 1681–1688.
Hatcher, J., Dignan,M.B., Schoenberg, N., 2011. Howdo rural health care providers and pa-
tients view barriers to colorectal cancer screening? Insights from appalachian ken-
tucky. Nurs. Clin. N. Am. 46, 181–192 (vi).
Haverkamp, D., Perdue, D.G., Espey, D., Cobb, N., 2011. A survey of Indian Health Service
and tribal health providers' colorectal cancer screening knowledge, perceptions,
and practices. J. Health Care Poor Underserved 22, 243–257.
Hawley, S.T., Levin, B., Vernon, S.W., 2001. Colorectal cancer screening by primary care
physicians in two medical care organizations. Cancer Detect. Prev. 25, 309–318.
Hawley, S.T., Volk, R.J., Krishnamurthy, P., Jibaja-Weiss, M., Vernon, S.W., Kneuper, S.,
2008. Preferences for colorectal cancer screening among racially/ethnically diverse
primary care patients. Med. Care 46, S10–S16.
Hawley, S.T., Mcqueen, A., Bartholomew, L.K., Greisinger, A.J., Coan, S.P., Myers, R., Vernon,
S.W., 2012. Preferences for colorectal cancer screening tests and screening test use in
a large multispecialty primary care practice. Cancer 118, 2726–2734.
Hoffman, R.M., Rhyne, R.L., Helitzer, D.L., Stone, S.N., Sussman, A.L., Bruggeman, E.E., Viera,
R., Warner, T.D., 2011. Barriers to colorectal cancer screening: physician and general
population perspectives, New Mexico, 2006. Prev. Chronic Dis. 8, A35.
Holden, D.J., Jonas, D.E., Porterﬁeld, D.S., Reuland, D., Harris, R., 2010. Systematic review:
enhancing the use and quality of colorectal cancer screening. Ann. Intern. Med. 152,
668–676.
891T. Brown et al. / Preventive Medicine Reports 2 (2015) 886–891Hrsa, 2012. Approved Uniform Data System Changes for 2012: Program Assistance Letter
2012–03. Health Services and Research Administration, Rockville, MD.
Jun, J., Oh, K.M., 2013. Asian and Hispanic Americans' cancer fatalism and colon cancer
screening. Am. J. Health Behav. 37, 145–154.
Kelly, K.M., Phillips, C.M., Jenkins, C., Norling, G., White, C., Jenkins, T., Armstrong, D.,
Petrik, J., Steinkuhl, A., Washington, R., Dignan, M., 2007. Physician and staff percep-
tions of barriers to colorectal cancer screening in Appalachian Kentucky. Cancer
Control 14, 167–175.
Klabunde, C.N., Frame, P.S., Meadow, A., Jones, E., Nadel, M., Vernon, S.W., 2003. A national
survey of primary care physicians' colorectal cancer screening recommendations and
practices. Prev. Med. 36, 352–362.
Klabunde, C.N., Vernon, S.W., Nadel, M.R., Breen, N., Seeff, L.C., Brown, M.L., 2005. Barriers
to colorectal cancer screening: a comparison of reports from primary care physicians
and average-risk adults. Med. Care 43, 939–944.
Klabunde, C.N., Lanier, D., Breslau, E.S., Zapka, J.G., Fletcher, R.H., Ransohoff, D.F., Winawer,
S.J., 2007. Improving colorectal cancer screening in primary care practice: innovative
strategies and future directions. J. Gen. Intern. Med. 22, 1195–1205.
Klabunde, C.N., Lanier, D., Nadel, M.R., McLeod, C., Yuan, G., Vernon, S.W., 2009. Colorectal
cancer screening by primary care physicians: recommendations and practices, 2006–
2007. Am. J. Prev. Med. 37, 8–16.
KLABUNDE, C.N., CRONIN, K.A., BREEN, N., WALDRON, W.R., AMBS, A.H., NADEL, M.R.,
2011. Trends in colorectal cancer test use among vulnerable populations in the
United States. Cancer Epidemiol. Biomark. Prev. 20, 1611–1621.
Kronborg, O., Fenger, C., Olsen, J., Jorgensen, O.D., Sondergaard, O., 1996. Randomised
study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348,
1467–1471.
Lee, J.K., Liles, E.G., Bent, S., Levin, T.R., Corley, D.A., 2014. Accuracy of fecal immunochem-
ical tests for colorectal cancer: systematic review and meta-analysis. Ann. Intern.
Med. 160, 171–181.
Levy, B.T., Nordin, T., Sinift, S., Rosenbaum, M., James, P.A., 2007. Why hasn't this patient
been screened for colon cancer? An Iowa Research Network study. J. Am. Board
Fam. Med. 20, 458–468.
Liles, E.G., Perrin, N., Rosales, A.G., Feldstein, A.C., Smith, D.H., Mosen, D.M., Schneider, J.L.,
2012. Change to FIT increased CRC screening rates: evaluation of a US screening out-
reach program. Am. J. Manag. Care 18, 588–595.
Liss, D.T., Baker, D.W., 2014. Understanding current racial/ethnic disparities in colorectal
cancer screening in the United States: the contribution of socioeconomic status and
access to care. Am. J. Prev. Med. 46, 228–236.
Liss, D.T., Petit-Homme, A., Feinglass, J., Buchanan, D.R., Baker, D.W., 2013. Adherence to
repeat fecal occult blood testing in an urban community health center network.
J. Community Health 38, 829–833.
Mandel, J.S., Bond, J.H., Church, T.R., Snover, D.C., Bradley, G.M., Schuman, L.M., Ederer, F.,
1993. Reducing mortality from colorectal cancer by screening for fecal occult blood.
Minnesota Colon Cancer Control Study. N. Engl. J. Med. 328, 1365–1371.
Meissner, H.I., Breen, N., Klabunde, C.N., Vernon, S.W., 2006. Patterns of colorectal cancer
screening uptake among men and women in the United States. Cancer Epidemiol.
Biomark. Prev. 15, 389–394.Nadel, M.R., Berkowitz, Z., Klabunde, C.N., Smith, R.A., Coughlin, S.S., White, M.C., 2010.
Fecal occult blood testing beliefs and practices of U.S. primary care physicians: serious
deviations from evidence-based recommendations. J. Gen. Intern. Med. 25, 833–839.
Nichols, C., Holt, C.L., Shipp,M., Eloubeidi, M., Fouad,M.N., Britt, K., 2009. Physician knowl-
edge, perceptions of barriers, and patient colorectal cancer screening practices. Am.
J. Med. Qual. 24, 116–122.
Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, J.R., Inamura, K., Kim, S.A.,
Kuchiba, A., Yamauchi, M., Imamura, Y., Willett, W.C., Rosner, B.A., Fuchs, C.S.,
Giovannucci, E., Ogino, S., Chan, A.T., 2013. Long-term colorectal-cancer incidence
and mortality after lower endoscopy. N. Engl. J. Med. 369, 1095–1105.
O'Malley, A.S., Beaton, E., Yabroff, K.R., Abramson, R., Mandelblatt, J., 2004. Patient and
provider barriers to colorectal cancer screening in the primary care safety-net. Prev.
Med. 39, 56–63.
Pignone, M., Rich, M., Teutsch, S.M., Berg, A.O., Lohr, K.N., 2002. Screening for colorectal
cancer in adults at average risk: a summary of the evidence for the U.S. Preventive
Services Task Force. Ann. Intern. Med. 137, 132–141.
Rim, S.H., Zittleman, L., Westfall, J.M., Overholser, L., Froshaug, D., Coughlin, S.S., 2009.
Knowledge, attitudes, beliefs, and personal practices regarding colorectal cancer
screening among health care professionals in rural Colorado: a pilot survey. J. Rural.
Health 25, 303–308.
Sarfaty, M., Doroshenk, M., Hotz, J., Brooks, D., Hayashi, S., Davis, T.C., Joseph, D., Stevens,
D., Weaver, D.L., Potter, M.B., Wender, R., 2013. Strategies for expanding colorectal
cancer screening at community health centers. CA Cancer J. Clin. 63, 221–231.
Sewitch, M.J., Burtin, P., Dawes, M., Yaffe, M., Snell, L., Roper, M., Zanelli, P., Pavilanis, A.,
2006. Colorectal cancer screening: physicians' knowledge of risk assessment and
guidelines, practice, and description of barriers and facilitators. Can. J. Gastroenterol.
20, 713–718.
Shapiro, J.A., Klabunde, C.N., Thompson, T.D., Nadel, M.R., Seeff, L.C., White, A., 2012.
Patterns of colorectal cancer test use, including CT colonography, in the 2010 National
Health Interview Survey. Cancer Epidemiol. Biomark. Prev. 21, 895–904.
Uspstf, 2008. Screening for colorectal cancer: U.S. Preventive Services Task Force recom-
mendation statement. Ann. Intern. Med. 149, 627–637.
Vart, G., Banzi, R., Minozzi, S., 2012. Comparing participation rates between immuno-
chemical and guaiac faecal occult blood tests: a systematic review and meta-
analysis. Prev. Med. 55, 87–92.
Woolf, S.H., 2000. The best screening test for colorectal cancer — a personal choice. N.
Engl. J. Med. 343, 1641–1643.
Yarnall, K.S., Pollak, K.I., Ostbye, T., Krause, K.M., Michener, J.L., 2003. Primary care: is there
enough time for prevention? Am. J. Public Health 93, 635–641.
Zapka, J.M., Klabunde, C.N., Arora, N.K., Yuan, G., Smith, J.L., Kobrin, S.C., 2011. Physicians'
colorectal cancer screening discussion and recommendation patterns. Cancer
Epidemiol. Biomark. Prev. 20, 509–521.
